Can a smartwatch help manage a rare liver disease? stanford study investigates
NCT ID NCT07631442
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study at Stanford University is testing whether wearable devices like smartwatches can help measure fatigue, sleep, and daily activity in people with primary biliary cholangitis (PBC), a chronic liver disease. Researchers will compare data from the wearables with patient questionnaires and lab tests to see if changes in activity or sleep patterns match disease activity. The study involves 30 participants and aims to find better ways to monitor PBC symptoms remotely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could show that wearable devices can reliably track PBC symptoms, potentially leading to better remote monitoring and earlier detection of disease changes.
- What could go wrong
- This is a small, early observational study (30 people) with no treatment being tested. It may not prove that wearables are useful for all PBC patients, and results might not lead to any direct changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford University School of Medicine
Redwood City, California, 94063, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common cholesterol drug help manage a rare liver disease?
- Artificial intelligence may help decide who gets a liver first
- AI may outsmart current system for liver transplant priority
- One pill may tame both itchy skin and stubborn liver disease
- New study tracks blood sugar in liver disease patients on common drug
- Promising new treatment for rare liver disease shows potential in Late-Stage trial